Two Sigma Investments, LP Teva Pharmaceutical Industries LTD Transaction History

Two Sigma Investments, LP

$41.1 Billion
Q2 2024

A detailed history of Two Sigma Investments, LP transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Two Sigma Investments, LP holds 137,600 shares of TEVA stock, worth $2.35 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

137,600

Previous 133,749 2.88%

Holding current value

$2.35 Million

Previous $1.89 Million 18.49%

% of portfolio

0.01%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$12.78 - $17.4 $49,215 - $67,007	3,851 Added 2.88%	137,600 $2.24 Million
Q1 2024 May 15, 2024	SELL	$10.67 - $14.43 $191,537 - $259,032	-17,951 Reduced 11.83%	133,749 $1.89 Million
Q4 2023 Feb 14, 2024	SELL	$8.12 - $10.63 $10,312 - $13,500	-1,270 Reduced 0.83%	151,700 $1.58 Million
Q3 2023 Nov 14, 2023	SELL	$7.48 - $10.7 $4.41 Million - $6.31 Million	-589,823 Reduced 79.41%	152,970 $1.56 Million
Q2 2023 Aug 14, 2023	SELL	$7.2 - $9.47 $2.92 Million - $3.85 Million	-406,156 Reduced 35.35%	742,793 $5.59 Million
Q1 2023 May 15, 2023	SELL	$8.36 - $11.37 $36.9 Million - $50.2 Million	-4,412,717 Reduced 79.34%	1,148,949 $10.2 Million
Q4 2022 Feb 14, 2023	BUY	$7.95 - $9.48 $2.21 Million - $2.64 Million	278,165 Added 5.26%	5,561,666 $50.7 Million
Q3 2022 Nov 14, 2022	BUY	$6.86 - $11.95 $31.7 Million - $55.3 Million	4,627,252 Added 705.11%	5,283,501 $42.6 Million
Q2 2022 Aug 15, 2022	BUY	$7.38 - $10.4 $1.03 Million - $1.45 Million	139,200 Added 26.92%	656,249 $4.94 Million
Q1 2022 May 16, 2022	SELL	$7.33 - $9.39 $3.39 Million - $4.35 Million	-463,147 Reduced 47.25%	517,049 $4.86 Million
Q4 2021 Feb 14, 2022	BUY	$7.9 - $10.19 $2.23 Million - $2.88 Million	282,576 Added 40.51%	980,196 $7.85 Million
Q3 2021 Nov 15, 2021	BUY	$8.38 - $10.18 $5.76 Million - $6.99 Million	686,986 Added 6460.28%	697,620 $6.8 Million
Q2 2021 Aug 16, 2021	BUY	$9.9 - $11.56 $105,276 - $122,929	10,634 New	10,634 $105,000
Q4 2020 Feb 16, 2021	SELL	$8.61 - $11.04 $818,363 - $1.05 Million	-95,048 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$8.57 - $12.69 $6.18 Million - $9.16 Million	-721,451 Reduced 88.36%	95,048 $856,000
Q2 2020 Aug 14, 2020	SELL	$8.12 - $13.12 $6.97 Million - $11.3 Million	-858,680 Reduced 51.26%	816,499 $10.1 Million
Q1 2020 May 15, 2020	SELL	$6.69 - $13.45 $9.89 Million - $19.9 Million	-1,477,722 Reduced 46.87%	1,675,179 $15 Million
Q4 2019 Feb 14, 2020	BUY	$6.53 - $10.72 $15.6 Million - $25.6 Million	2,389,053 Added 312.77%	3,152,901 $30.9 Million
Q3 2019 Nov 14, 2019	BUY	$6.16 - $9.6 $4.64 Million - $7.23 Million	752,948 Added 6907.78%	763,848 $5.26 Million
Q2 2019 Aug 14, 2019	SELL	$8.12 - $15.72 $24.6 Million - $47.6 Million	-3,030,927 Reduced 99.64%	10,900 $101,000
Q1 2019 May 15, 2019	BUY	$15.58 - $20.01 $47.4 Million - $60.9 Million	3,041,827 New	3,041,827 $47.7 Million
Q4 2018 Feb 14, 2019	SELL	$14.59 - $23.84 $5.43 Million - $8.87 Million	-371,883 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$21.06 - $25.65 $33.4 Million - $40.7 Million	-1,587,975 Reduced 81.03%	371,883 $8.01 Million
Q2 2018 Aug 14, 2018	BUY	$16.77 - $24.71 $29.6 Million - $43.6 Million	1,763,766 Added 899.46%	1,959,858 $47.7 Million
Q1 2018 May 15, 2018	SELL	$16.68 - $22.07 $18.5 Million - $24.4 Million	-1,107,214 Reduced 84.95%	196,092 $3.35 Million
Q4 2017 Feb 14, 2018	BUY	$11.23 - $19.1 $13.5 Million - $23 Million	1,204,574 Added 1220.04%	1,303,306 $24.7 Million
Q3 2017 Nov 14, 2017	BUY	$15.41 - $32.17 $1.52 Million - $3.18 Million	98,732	98,732 $1.74 Million

Others Institutions Holding TEVA

# of Institutions

624

Shares Held

565M

Call Options Held

25.2M

Put Options Held

5.08M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Teva Pharmaceutical Industries LTD Transaction History